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A B S T R A C T
Background: Although eastern Asian countries are exposed to high levels of air pollution, the impact of
long-term exposures to fine particulate matter (PM2.5) air pollution on all-cause and cardiovascular
mortality is not well identified. We assessed the relationship between long-term PM2.5 exposure and all-
cause/cardiovascular mortalities.
Methods: We included 436,933 subjects who received national health examinations from the Korean
National Health Insurance Service-based National Sample Cohort. We matched subjects’ residential-
address areas with hourly-measurements of PM2.5 concentration data. We estimated the risk of mortality
with average PM2.5 exposure during the study period using a Cox proportional-hazards model.
Results: During 1,683,271 personyears, all-cause and cardiovascular mortalities were observed in
6432 and 1603 subjects (382 and 95 per 100,000 personyears, respectively). An increase in 10 mg/m3 in
PM2.5 was associated with increases in all-cause and cardiovascular mortalities by 3.4 % [2.7–4.1] and
4.7 % [3.6–5.8], respectively (each p < 0.001). PM2.5 was linearly and significantly correlated with these
all-cause and cardiovascular mortalities above 18 mg/m3 of PM2.5 (p < 0.001), but it was not significant
below 18 mg/m3 of PM2.5. To investigate the specific PM2.5 concentration for raising cardiovascular
mortality more, we analyzed the sensitivities/specificities for different PM2.5 levels, and 18 mg/m3
showed the highest Youden’s index (sensitivity + specificity-1) with c-index of 0.85 (0.84–0.86). PM2.5
effect on all-cause mortality was more profound in subjects with previous myocardial infarction
compared to the opposite population.
Conclusions: In the Korean general population exposed to high-air pollution, long-term PM2.5 exposure
was linearly associated with increased risk for all-cause and cardiovascular mortality, especially above
18 mg/m3 of PM2.5.
© 2019 Published by Elsevier Ltd on behalf of Japanese College of Cardiology. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Epidemiological studies from Western countries have sug-
gested that elevated ambient particulate matter <2.5 mm (PM2.5)
in aerodynamic diameter are consistently associated with adverse* Corresponding authors.
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creativecommons.org/licenses/by-nc-nd/4.0/).cardiovascular events or even mortality [1]. The suggested
mechanism is that these events are associated with various
systemic inflammatory responses after inhalation [2–4]. Current
air quality standards in the USA and European societies are based
on a 3-year average of the annual arithmetic means of PM2.5
concentration [5,6], but clear evidence of a threshold PM2.5
concentration associated with increased risks of cardiovascular or
all-cause mortality is lacking [1,7,8]. As the average air pollutant
concentration is much lower in the USA [5] and European [6]
countries (Supplementary Fig. 1) compared to eastern Asian [9]
countries (who are affected by Asian dust phenomenon from theiology. This is an open access article under the CC BY-NC-ND license (http://
I.-S. Kim et al. / Journal of Cardiology 75 (2020) 549–558550industrial facilities and the Gobi Desert in Central Asia thought to
produce more than 20 % of global dust emissions via westerly
wind) [10,11]; the effect sizes could be lower in the USA and
European countries. Besides, concentration-responsive harmful
effects of long-term exposures of PM2.5 on cardiovascular mortality
have not been well-identified in these countries exposed to higher
levels of air pollution. Accordingly, accurately identifying such
exposure effects and allocating necessary attention and resources
to the underlying conditions are crucial for successful patient care
and prophylaxis.
We conducted a large, comprehensive study using a Korean
cohort covering the general population in an attempt to identify
the association between long-term exposure to PM2.5 and all-
cause/cardiovascular mortalities. We also investigated whether
there was the specific PM2.5 concentration more associated with
increased risks of these mortalities. Subgroup analyses were
performed to investigate PM2.5-related mortality according to
cardiovascular comorbidities.
Methods
The study protocol adhered to the ethical guidelines of the
1975 Declaration of Helsinki. The protocol was approved by the
Institutional Review Board of Yonsei University College of
Medicine, and informed consent was waived.
Data source
This study was based on the Korean National Health Insurance
Service (NHIS)-based National Sample Cohort (NSC) database. This
sample cohort (n = 1,025,340) was extracted by probability
sampling, not by a randomized sampling method, from all
beneficiaries of the National Health Insurance and National
Medical Aid in 2002 based on the entirety of the national cohort
data. Systematic sampling was acquired from each of the
1476 strata based on age, sex, eligibility status, socioeconomic
status, and income level, with the sample size proportionate to the
cohort size of the strata. The sample’s representativeness was
examined previously by comparing the sample and the entire
Korean population [12].
The NSC database consisted of the three following datasets: (i)
sociodemographic information of the beneficiaries, (ii) medical
claims including information on diagnoses based on the 10th
revision of the International Classification of Disease (ICD-10)
codes, outpatient (including individual physician office) visits,
admission, and treatment, (iii) and National Health Examination
data of the cohort members. The National Health Examination
dataset was created for the entire Korean population from 2002 to
2013 by the National Health Insurance Corporation. The National
Health Examination was conducted biennially with regular blood
tests including serum creatinine (mL/min), chest X-rays, physical
examinations, and detailed questionnaires regarding medical
history and lifestyle behaviors (smoking and alcohol intake). The
death registration database of the Korea National Statistical Office,
which includes the date and cause of death, was linked with the
NHIS cohort database. Every subject in the sample cohort was
linked using Korean social security numbers, and all social security
numbers were deleted after constructing the cohort by assigning
serial numbers to each subject to prevent leakage of personal
information.
Study cohort
This study used the Korean NHIS-based NSC database from
2002 to 2013 [12]. Among the entire South Korean population
(about 47 million people in 2002), 96.6 % were registered in theNHIS. About 70 % of the entire cohort underwent a National Health
Examination. Adults over 18 years of age who received a National
Health Examination at least once between 2009 and 2013
(n = 506,805) among the total population (n = 1,025,340) were
included in the NHIS-NSC (NHIS-2016-2-189) (Fig.1) [12]. Each was
followed from health examination day to 31 December 2013. To
apprehend enrolled subjects’ past medical history, they were
screened from January 2002 to December 2008 (2002-2008:
disease-free baseline period). Past medical histories, such as heart
failure, hypertension, diabetes mellitus, stroke, myocardial infarc-
tion (MI), peripheral vascular disease, or atrial fibrillation
diagnosed before undergoing a health examination, were assessed
based on the ICD-10 codes (Supplementary Table 1). Each diagnosis
was defined as the first occurrence during at least two different
days of outpatient hospital visits or on the first hospital admission
(Supplementary Table 1) [13,14]. The following exclusion criteria
were applied (Fig. 1): (i) under the age of 18 years, (ii) changed
residence to another region in 2009–2013, and (iii) missing data
regarding residential-address, smoking status, and alcohol intake.
A final population of 436,933 subjects was included in the analysis
(Fig. 1). For sensitivity analysis, we excluded those with current- or
former-smokers because smoking status is a major confounding
factor to analyze true air pollution effects. After that, a population
of 272,264 subjects with non-smokers was included in the
sensitivity analysis to investigate the robustness of our main
analysis. The cohort was followed to the time of death; to a
condition disqualifying receipt of the NHIS services, such as
emigration; or to the end of the study (31 December 2013).
Air pollution measurements and national ambient air quality
standards
PM2.5, O3, temperature, and humidity were measured hourly
during the study period at the 313 sites of the Korean Nationwide
Meteorological Observatory by the Korean Department of Envi-
ronmental Protection. The entire Korean area was divided into
256 residential-addresses, including 74 address areas within
metropolitan areas (average 73 km2). The nearest monitor to each
residence was identified and used to assess the average annual
pollutant concentration for each study subject [15]. Long-term
average (during the total study period for each subject) air
pollutant concentrations were calculated from these hourly
measurements for each site.
Geographically-based long-term average of each air pollutant
concentration (PM2.5 and O3) was measured hourly by the
monitoring facilities during the study period [16], and each
residential-address area was matched with the nearest monitoring
facilities. If a residential area was halfway between two monitors,
average concentration of these monitors was applied at this
residential area.
The annual National Ambient Air Quality Standards (NAAQS) of
PM2.5 for each society differed from country to country: <12, <25,
<10, and <15 mg/m3 for the USA, European Union, World Health
Organization, and Korea, respectively [5,9,17].
Clinical variables and outcomes
The clinical variables and the frequency and proportion of all-
cause or cardiovascular mortalities were described depending on
the Korean annual NAAQS of PM2.5 (15 mg/m3) [9]. The primary
outcomes were the concentration-response relationships between
PM2.5 and all-cause or cardiovascular mortality. All-cause mortali-
ty was determined by counting the number of deaths of any cause.
Cardiovascular mortality was defined as the immediate cause of
death provided on the death certificate focusing on MI (I21-23),
heart failure (I11.0, I50), peripheral vascular diseases (I71-74), and
Fig. 1. Study cohort and included subjects in NHIS-NSC (overall general population).
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we investigated cerebral bleeding and infarction (ICD-10 code: I60-
64) and excluded transient ischemic attacks (G45) or other kinds of
thromboembolisms. The accuracy of the diagnosis of stroke in the
NHIS database was also previously validated [12].
Life-style factors
Past medical histories were analyzed using medical claim data
with ICD-10 codes (Supplementary Table 1) and using question-
naires regarding disease history and measurements of blood
pressure and fasting blood glucose levels collected during health
examinations. Subjects were classified as obese [body mass index
(BMI) 27.5 kg/m2], overweight (23.0–27.4 kg/m2), normal BMI
(18.5–22.9 kg/m2), and underweight (<18.5 kg/m2) [19]. Smoking
status was classified as non-, <20 packyears or 20 packyears
(former- or current-) smokers. The amounts of alcohol intake were
classified as 0–220.5 g/week or 220.5 g/week.
Statistical analyses
Cox proportional-hazards model regression analyses were used
to analyze the association between average PM2.5 concentration
during the study period and all-cause or cardiovascular mortalities
with adjustments for confounding variables. Models adjusting for
the clinical variables [including age, sex, body mass index (BMI),
socioeconomic status, heart failure, hypertension, dyslipidemia,
diabetes, previous stroke/transient ischemic attack (TIA) history,
previous MI or peripheral vascular disease, serum estimated
glomerular filtrate rate, and lifestyle factors such as smoking status
and alcohol intake] were used to assess these associations [20]. To
adjust for potential confounders, we fit a two-pollutant Cox-
regression analysis [1,21] to assess correlations between eachpollutant and mortality (all-cause and cardiovascular). These
mortalities associated with PM2.5 exposure was adjusted for O3
exposure each. Mortality events were analyzed with geographi-
cally-based long-term average of each air pollutant concentration
during the study period for each subject. Included subjects were
followed from their national health examination until develop-
ment of death, disqualification (immigration), or the end of study
in Cox-regression analysis.
We assumed that the study subjects were exposed to ambient
air pollution within their residential-address areas during the
study period [1]. Individual subjects were matched with average
air pollution concentrations during the study period from their
nearest monitoring facilities according to their residential address.
The relationships between PM2.5 and all-cause or cardiovascular
mortality were analyzed by a Cox proportional-hazard model
regression analysis using a generalized estimating equation
approach with a random effects analysis [22,23].
To minimize the effects of the potential sources of confounders
and to investigate the robustness of our study results, a sensitivity
analysis was performed: an analysis for subjects with non-smokers
(see Methods – Study Cohort) to investigate the pure air pollution
effect on mortality in these population. Linear estimates of hazard
ratio about concentration-response relationship between air
pollution and mortality were tested by log-linear model with a
thin-plate spline for PM2.5 with adjusting age and sex. Also, we
estimated the predictive accuracy of PM2.5 for all-cause and
cardiovascular mortality by calculating the c-index on the basis of
the receiver operating characteristic (ROC) curve from logistic
regression models. To investigate the specific PM2.5 concentration
for raising these mortalities more, we analyzed the sensitivities
and specificities for different PM2.5 levels and determined the point
having the highest Youden’s index (sensitivity + specificity - 1)
[24].
Table 1
Cohort characteristics according to average PM2.5 level (15 or <15 mg/m3 based on the annual NAAQS of Korea) (n = 436,933).
PM2.5 concentration
Variables Entire cohort 15 mg/m3 <15 mg/m3
Person, n 436,933 353,209 83,724
All-cause deaths, n (per 100,000 personyear) 6432 (382) 5302 (390) 1130 (350)
Cardiovascular deaths, na (per 100,000 personyear) 1603 (95) 1496 (98) 107 (82)
Median follow-up year 4.0 4.0 4.0
Average PM2.5 concentration (㎍/m3) 18.8 20.3 12.2
Male sex (%) (50.1) (50.1) (50.2)
Age, years (mean) 47.8 47.3 49.6
75 (%) (3.5) (3.4) (4.1)
BMI, kg/m2 (mean) 23.7 23.6 23.9
Obesity (BMI  27.5 kg/m2) (%) (11.9) (11.6) (12.9)
Smoking, pyrs (mean) 6.1 6.0 6.3
Non- (%) (61.4) (61.2) (62.1)
<20pyrs (%) (24.3) (24.5) (23.6)
20pyrs (%) (12.9) (12.8) (13.3)
Alcohol intake, g/week (mean) 62.8 62.6 63.5
220.5 g/week (8.0) (8.0) (8.2)
Socioeconomic status, higherb (%) (60.5) (60.1) (62.3)
Hypertension (%) (22.1) (20.5) (29.2)
Diabetes (%) (6.4) (6.0) (8.1)
Dyslipidemia (%) (19.6) (18.8) (23.2)
CKD (%) (6.0) (5.9) (6.5)
Previous MI (%) (1.0) (1.0) (1.3)
Peripheral vascular disease (%) (2.5) (2.4) (2.8)
HF (%) (2.5) (2.4) (2.9)
Previous stroke/TIA (%) (3.9) (3.7) (4.7)
Previous history of AF (%) (1.6) (1.7) (1.2)
Medications at enrollment
Antiplatelet agent (%) (10.0) (9.5) (12.2)
Beta-blocker (%) (7.8) (7.4) (9.6)
Statin (%) (8.5) (8.1) (10.2)
AF, atrial fibrillation; BMI, body mass index (kg/m2); CKD, chronic kidney disease; HF, heart failure; MI, myocardial infarction; NAAQS, National Ambient Air Quality
Standards; PM2.5, particulate matter <2.5 mm in diameter; pyrs, packyears; TIA, transient ischemic attack.
a Cardiovascular death was defined as the immediate cause of death provided on the death certificate focusing on MI (I21-23), HF (I11.0, I50), peripheral vascular diseases
(I71-74), and ischemic and hemorrhagic stroke (I60-64) (See Methods).
b In our cohort, socioeconomic status was divided into 11 categories (010) and was applied in main analysis. In this Table, socioeconomic status was divided into two
groups: higher (610 categories of income level) and lower (05 categories of income level).
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proportionality of the hazards assumption was checked with a log
minus log graph and a test on the Schoenfeld residuals, and as a
consequence, the test results were found to be valid for each life-
style factor. All-cause and cardiovascular mortality events in
Figs. 2, 4, and 5 are represented as ‘age-, sex-adjusted mortality
event rates per 100,000 personyear’ to provide more accurate
comparisons among groups because the follow-up time periods
differed among groups. Age- and sex-adjustment was calculated by
age and sex stratification with dividing 5-year of age groups. All
statistical analyses were performed with R software (version 3.5.2;
R Project for Statistical Computing) and SAS software (version 9.2,
SAS Institute, Cary, NC, USA).
Results
Baseline characteristics
Overall, the entire cohort included436,933 subjects whoreceived
national health examinations within 2009–2013 with 1,683,271
personyears of follow-up. Total all-cause and cardiovascular deaths
occurred in about 382 and 95 (per 100,000 personyear) of the study
population, respectively. Daily PM2.5 levels were within 10–45mg/
m3 during 77.0 % of measurement days of the study period
(Supplementary Fig. 2). To understand cohort characteristics
according to average PM2.5 level, we divided subjects into average
PM2.5 concentration exposure 15 mg/m3 or <15 mg/m3 groups
based on NAAQS of Korea. The average PM2.5 concentrations during
the study period for these groups were measured as 20.3 and12.2 mg/m3, respectively (Table 1). Although younger with lower
proportions of hypertension and diabetes histories, there were more
all-cause (390 versus 350 subjects per 100,000 personyears,
p < 0.001) and cardiovascular deaths (98 versus 82 subjects per
100,000 personyears, p < 0.001) when average PM2.5 concentration
was above 15 mg/m3 compared to the remainder of the population
during median 4.0 years of follow-up (Table 1). The risks of all-cause
and cardiovascular mortalities are described in Table 2.
Ambient PM2.5 air pollution is associated with increased all-cause and
cardiovascular mortality
(Air pollution and meteorological measurements are described
in detail in the Supplementary Results.)
Fig. 2A and B show age- and sex-adjusted mortality events (per
100,000 personyears) for all-cause and cardiovascular causes, and
each increase of PM2.5 concentration was associated with
increased risk (each p < 0.01). In Cox proportional-hazards models
using covariates of clinical variables, an increase in PM2.5
concentration of 10 mg/m3 was associated with increased risks
of all-cause [HR 1.034 (1.027–1.041), p < 0.001] and cardiovascular
[HR 1.047 (1.036–1.058), p < 0.001) mortality (Table 3; and
Supplementary Table 3 for sensitivity analysis).
Above 18 mg/m3 of PM2.5 concentration associated with more
increased risks of mortality
We fit age- and sex-adjusted Cox proportional-hazards log-
linear models with thin-plate spline curves to PM2.5, and an
Table 2
Comorbidities and the risk of mortality based on Cox regression analysis (overall general population, n = 436,933).
All-cause death Cardiovascular deathc
Adjusted HR (95 % CI)b p-value Adjusted HR (95 % CI)b p-value
PM2.5 (by 10 mg/m3 increase)a 1.034 (1.027–1.041) <0.001 1.047 (1.036–1.058) <0.001
Age 1.099 (1.097–1.102) <0.001 1.112 (1.107–1.118) <0.001
Male sex 2.003 (1.889–2.124) <0.001 1.519 (1.342–1.720) <0.001
BMI 1.122 (1.112–1.131) <0.001 1.134 (1.050–1.153) <0.001
Hypertension 1.252 (1.177–1.331) <0.001 1.531 (1.343–1.747) <0.001
Diabetes 1.558 (1.458–1.664) <0.001 2.191 (1.950–2.461) <0.001
Dyslipidemia 1.152 (1.086–1.222) <0.001 1.176 (1.050–1.319) 0.005
Heart failure 1.539 (1.421–1.667) <0.001 1.694 (1.480–1.938) <0.001
CKD 1.345 (1.264–1.432) <0.001 1.550 (1.384–1.736) <0.001
Previous MI 1.405 (1.210–1.632) <0.001 1.473 (1.216–1.785) <0.001
Peripheral vascular disease 1.085 (1.008–1.169) <0.001 1.126 (1.025–1.249) <0.001
Previous stroke/TIA 1.325 (1.237–1.426) <0.001 1.763 (1.564–1.987) <0.001
Previous history of AF 1.314 (1.148–1.496) <0.001 1.536 (1.167–1.968) <0.001
Smoking (non-smoker vs. smoker) 1.162 (1.076–1.256) <0.001 1.099 (0.932–1.295) 0.262
Alcohol intake habit (<220.5 vs.  220.5 g/week) 1.331 (1.242–1.426) <0.001 1.227 (1.062–1.418) 0.005
AF, atrial fibrillation; BMI, body mass index; CI, confidence interval; CKD, chronic kidney disease with estimated glomerular filtration rate less than 60 mL/min; HR, hazard
ratio; MI, myocardial infarction; PM2.5, particulate matter <2.5 mm in diameter; TIA, transient ischemic attack.
a To adjust for potential confounders, we fit a two-pollutant Cox regression analysis to assess the correlations between PM2.5 and mortality by each cause. Risks of all-
cause and cardiovascular mortality associated with PM2.5 exposure were adjusted for O3 exposure.
b Clinical variables-adjusted hazard ratios are shown. Clinical variables were age, sex, BMI, socioeconomic status, heart failure, hypertension, dyslipidemia, diabetes,
previous stroke/TIA history, previous MI or peripheral vascular disease, serum estimated glomerular filtrate rate, smoking status and alcohol intake habit.
c Cardiovascular death was defined as the immediate cause of death provided on the death certificate focusing on MI (I21-23), heart failure (I11.0, I50), peripheral vascular
diseases (I71-74), and ischemic and hemorrhagic stroke (I60-64) (See Methods).
Fig. 2. (A and B) All-cause (A) and cardiovascular (B) mortality events according to PM2.5 concentration. Association trends were analyzed by linear regression for each
concentration with age- and sex-adjusted mortality event rates.
(C and D) Concentration-response relationships between long-term exposures of PM2.5 and all-cause (C) and cardiovascular (D) mortalities tested by log-linear model with
thin-plate splines (age- and sex-adjusted HRs). C and D panel also showed the specific PM2.5 concentration (which showed lower 95 % CI more than 1.0 of HR) being associated
with more increased mortalities.
CI, confidence interval; HR, hazard ratio; PM2.5, particulate matter <2.5 mm in diameter.
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increased risks for all-cause and cardiovascular mortalities (Fig. 2C
and D). Relationships between PM2.5 and these mortalities were
almost linear above 18.0 mg/m3. No significant correlations for
these mortalities below 18.0 mg/m3 of PM2.5 (HR with its 95 % CI
were more than 1.0 above 18.0 mg/m3 of PM2.5, Fig. 2C and D) were
demonstrated (Supplementary Fig. 3 for sensitivity analysis).Fig. 3A and B show the ROC curves based on PM2.5 concentration
for these associations with all-cause and cardiovascular mortality.
The c-indices of PM2.5 for the prediction models concerning these
associations were 0.82 (0.81–0.83) and 0.85 (0.84–0.86), respective-
ly. The specific levels of PM2.5 for being associated with greater
increased risk of these mortalities were both analyzed as 18 mg/m3
based on the highest Youden’s index (Fig. 3A, B, and Supplementary
Table 3
PM2.5 and the risk of mortality (overall general population, n = 436,933).
Mortality risksa
(by 10 mg/m3 increase of PM2.5)
HR (95 % CI) p-value
All-cause deaths
Crude (95 % CI) 1.075 (1.067–1.082) <0.001
Adjusted (95 % CI)b 1.034 (1.027–1.041) <0.001
Cardiovascular deathsc
Crude (95 % CI) 1.097 (1.086–1.108) <0.001
Adjusted (95 % CI)b 1.047 (1.036–1.058) <0.001
CI, confidence interval; HF, heart failure; HR, hazard ratio; MI, myocardial
infarction; PM2.5, particulate matter <2.5 mm in diameter.
a To adjust for potential confounders, we fit a two-pollutant Cox regression
analysis to assess the correlations between PM2.5 and mortality by each cause.
Risks of all-cause and cardiovascular mortality associated with PM2.5 exposure
were adjusted for O3 exposure.
b Clinical variables-adjusted hazard ratios are shown. Clinical variables were
age, sex, body mass index, socioeconomic status, heart failure, hypertension,
dyslipidemia, diabetes, previous stroke/transient ischemic attack history,
previous myocardial infarction or peripheral vascular disease, serum estimated
glomerular filtrate rate, smoking status, and alcohol intake habit.
c Cardiovascular death was defined as the immediate cause of death provided
on the death certificate focusing on MI (I21-23), HF (I11.0, I50), peripheral
vascular diseases (I71-74), and ischemic and hemorrhagic stroke (I60-64) (See
Methods).
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for sensitivity analysis).
For comprehensive analysis, we divided subjects according to
18 mg/m3 or <18 mg/m3 of average PM2.5 exposure level. There
were more all-cause (388 versus 376 subjects per 100,000
personyear, p < 0.001) and cardiovascular deaths (102 versusFig. 3. (A and B) ROC curves of PM2.5 in predicting all-cause (A) and cardiovascular (B) m
cardiovascular mortality were 0.82 and 0.85, respectively. The  18 mg/m3 of PM2.5 con
(C and D) Kaplan-Meier curves of all-cause (C) and cardiovascular (D) mortality according
and 18 mg/m3.
AUC, area under the curve; PM2.5, particulate matter <2.5 mm in diameter; ROC, receiv88 subjects per 100,000 personyear, p < 0.001) when average
PM2.5 concentration was above 18 mg/m3 compared to the
remainder of the population during the study period (Supplemen-
tary Table 8; and Supplementary Table 9 for sensitivity analysis).
Kaplan-Meier graphs also showed that there were higher all-cause
or cardiovascular deaths when average PM2.5 concentration was
above 18 mg/m3 compared to the remainder of the population
(each log-rank p < 0.001, Fig. 3C and D).
Subgroup analyses
In all subgroups, the increase of PM2.5 increased the risk of all-
cause (Fig. 4) and cardiovascular deaths (Fig. 5). PM2.5 exposure
effect on all-cause mortality was more profound in subjects with
previous MI compared to the opposite population (interaction
p = 0.018, Fig. 4). There were nonsignificant higher trends of
increased risk of all-cause or cardiovascular mortality among men,
older subjects (60 years); subjects with a history of heart failure,
atrial fibrillation, and stroke; and those who were obese (BMI
 27.5 kg/m2) or underweight (BMI < 18.5 kg/m2) than in those
who were not (Fig. 3A and 3B). Interestingly, these correlations
were diminished among subjects who were heavy smokers (20
packyears) compared to non-smokers [each HR was 1.026 (1.010–
1.042) and 1.044 (1.035–1.053) with interaction p = 0.029] (Fig. 4).
Discussion
Main findings
In this nationwide study using a large cohort covering the
Korean general population, which showed much higher level ofortality. The c-indices on the basis of the AUC for PM2.5 in predicting all-cause and
centration showed the highest Youden’s index (sensitivity + specificity - 1).
 to PM2.5 level (overall general population with 436,933 subjects): PM2.5 <18 mg/m3
er operating characteristics.
Fig. 4. Effect of PM2.5 exposure on all-cause mortality in different subgroups (overall general population with 436,933 subjects). The HRs were adjusted by age, sex, BMI, SES,
HF, HTN, dyslipidemia, DM, previous stroke/transient ischemic attack history, previous MI or peripheral vascular disease, serum estimated glomerular filtrate rate, smoking
status, and alcohol intake habit.
AF, atrial fibrillation; BMI, body mass index; DM, diabetes mellitus; HF, heart failure; HR, hazard ratio; HTN, hypertension; MI, myocardial infarction; PM2.5, particulate matter
<2.5 mm in diameter; SES, socioeconomic status.
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exposure of PM2.5 was associated with increased risks of all-cause
and cardiovascular mortality. An increase in PM2.5 concentration
by 10 mg/m3was also associated with a further increased risk of all-
cause and cardiovascular mortality by 3.7 % and 5.2 %, respectively,
even after adjusting for clinical variables. We also demonstrated
that a specific level of PM2.5 concentration as 18 mg/m3 was
associated with more increased risks of all-cause and cardiovas-
cular mortality.
Clinical importance of the effects of air pollution on mortality
Many studies, including meta-analyses, have investigated
associations between air pollution and mortality [1,7,25]. Long-
term exposure to ambient air pollution contributes to various
adverse cardiovascular effects, including MI, stroke, heart failure
[3], or death [2,21]. However, current air quality standards in the
US and European societies are based on a 3-year average of the
annual arithmetic means of PM2.5 concentration [5,6], because
previous epidemiological studies reported that it was not obvious
whether there was threshold PM2.5 concentration associated with
increased risk of mortality [1,8,26]. Air pollution levels of US and
European societies were much lower compared to Asian countries
(Supplementary Fig. 1; 2017 annual average PM2.5 concentration
was 25.1 mg/m3 in Korea, whereas 7.4 mg/m3 in USA, and 10.4–
12.1 mg/m3 in European countries). However, the impact of air
pollution in eastern Asian countries with high PM2.5 concentration
has not been well-identified. This large nationwide cohort study
showed continuous and linearly increasing associations between
long-term PM2.5 exposure and mortality in subjects from the
Korean general population. These correlations were shown
consistently across all subgroups. And due to a large proportionof the population living in urban areas who are exposed to levels of
PM2.5 exceeding national air quality standards, attention to higher
levels of PM2.5 air pollution becomes particularly important [27].
The level of PM2.5 associated with more increased risks of mortality
Although there have been many studies on the association
between mortality and certain air pollutants [28,29], less is known
about the effect of ambient PM2.5 air pollution on mortality in
Asian general populations. Previous studies also demonstrated
significant correlations between PM2.5 air pollution and mortality,
however, it had not been clear whether there was a threshold PM2.5
concentration associated with increased risks of mortality [1,7]. A
previous meta-analysis of 22 European cohorts that included 367
000 people and reported 29 000 mortalities included subjects with
clinical cardiovascular conditions or comorbidities with residual
confounding factors that affect mortality more than air pollution
[28,29]. In contrast, our study was (i) a large-scale adult cohort
(18years) of over 400,000 subjects who underwent National
Health Examinations. This allowed for adjustment for major
confounding factors such as smoking history, alcohol intake habit,
residential information, and socioeconomic status data. Also, the
(ii) long-term follow-up duration was extensive, 1,683,271
personyears. (iii) This allowed us to reveal a small but significant
concentration-response relationship between PM2.5 concentration
and all-cause or cardiovascular mortality in our Korean general
population cohort. Further, (iv) we demonstrated the specific PM2.5
concentration associated with more increased risks of these
mortalities, which was not previously well-studied. These (v)
associations between PM2.5 and all-cause mortality were more
profound in subjects with previous MI and non-smokers compared
to the opposite population. Since inhaled particulate pollutants
Fig. 5. Effect of PM2.5 exposure on cardiovascular mortality in different subgroups (overall general population with 436,933 subjects). The HRs were adjusted by age, sex, BMI,
SES, HF, HTN, dyslipidemia, DM, previous stroke/transient ischemic attack history, previous MI or peripheral vascular disease, serum estimated glomerular filtrate rate,
smoking status, and alcohol intake habit.
AF, atrial fibrillation; BMI, body mass index; DM, diabetes mellitus; HF, heart failure; HR, hazard ratio; HTN, hypertension; MI, myocardial infarction; PM2.5, particulate matter
<2.5 mm in diameter; SES, socioeconomic status.
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inflammatory reactions [30], these adverse inhalation effects
can be diminished in patients with chronic lung parenchymal
diseases [31]. In this study, there were more subjects with chronic
obstructive pulmonary disease (COPD) among heavy smokers
(20packyears) compared to those among non-smokers (3.9 % vs
2.5 %, p < 0.001). And PM2.5 effects on all-cause mortality were
more profound in subjects without COPD compared to subjects
with COPD [adjusted HR 1.037 (1.029–1.045) vs adjusted HR 1.022
(1.008–1.037), p-value for interaction <0.001). We also (vi)
excluded subjects who moved to another region during the study
period in an attempt to identify the consistent effect of air
pollution on mortality, and (vii) sensitivity analyses with including
only non-smokers demonstrated the robustness of our main
results. We were also able to investigate the relationship between
air pollution and cardiovascular causes of death by linking national
health insurance administrative data and death certificate
information from the national statistical office.
Clinical implications
Our study supports a small but significant association between
PM2.5 and both all-cause or cardiovascular mortality, which may be
a modifiable risk factor in our study population.
Additionally, our study demonstrated the specific PM2.5
concentration for further raising these mortalities which had
not been well-studied previously. And we also investigated
susceptible subgroups associated with increased risks of these
mortalities, which may offer the important cosmopolitical
information to general population or even to national adminis-
trations dealing with public health for redefining the PM2.5
standards.Limitations
Our study, nonetheless, had its limitations. We excluded subjects
who moved to another region within the study period, this may not
have fully reflected the subjects’ specific locations (such as subjects
who worked outside away, or at home) [32]. An epidemiological
study investigated that living close to intense traffic roads was
associated with increased cardiovascular inflammatory markers
[33], however, our study did not investigate these aspects. In
addition, we could not identify the exact hour of subjects' death or
specific events because this study was from the claims data. For these
reasons, the analysis of acute exposure effects was thought as it may
draw somewhat biased results from our cohort data, and further
investigations are needed [34]. Compared to the previous epidemi-
ological study [32] which was performed with the Medicare
population primarily consisting of subjects older than 65 years
and cause-specific mortality were not reported, our study included
young healthy subjects and investigated the associations between
PM2.5 exposure and cardiovascular mortality also.
Although we analyzed the effect of air pollution on mortality
with adjustment for age and sex, some confounders (e.g. noise
[35]) were not considered in this study. Even so, our overall results
were consistent after adjusting for additional clinical variables
(BMI, socioeconomic status, heart failure, hypertension, dyslipi-
demia, diabetes, previous stroke/TIA history, previous MI or
peripheral vascular disease, serum estimated glomerular filtrate
rate, smoking, and alcohol intake status). Because smoking history
and alcohol intake behavior were obtained from questionnaires
given during the national health examinations, careful interpreta-
tion of these results is needed. Also, smoking is a major
confounding factor (PM2.5 concentration inside smoky rooms are
more than 600 mg/m3) for analyzing air pollution effects [36],
I.-S. Kim et al. / Journal of Cardiology 75 (2020) 549–558 557however, smokers were more than one third in this population and
they included many subjects with cardiovascular risk factors
including hypertension, diabetes, dyslipidemia, and previous MI,
which were important risk factors of cardiovascular mortality.
Therefore, we thought that excluding these many smokers could
even draw somewhat biased results for analyzing all-cause and
cardiovascular mortalities, then, we analyzed with including
smokers as in a recent epidemiological study about PM2.5 and
mortality [1]. Sensitivity analyses with non-smokers to analyze the
true air pollution effects showed consistency (Supplementary
Tables 3, 6, 7, 9, and Supplementary Figs. 3 and 4). However, the air
pollution data from different sources (such as diesel, benzene, or
metal compounds) were not available, therefore, we could analyze
with only measured air pollutants. Because smoking history and
alcohol intake behavior were obtained from the questionnaires
during the national health examinations, careful interpretation of
these results is needed. So, we used multivariable adjusted Cox-
regression analysis and sensitivity analyses excluding subjects who
were current- or former-smokers, and overall results were also
consistent. Although the acute effect of PM2.5 for endothelial
dysfunction was studied recently [37,38], we did not investigate
associations between air pollution and vascular/tissue inflamma-
tion or myocardial repolarization, and thus the mechanism behind
the relationship between exposure to air pollution and clinical
cardiovascular diseases remains unclear.
Conclusions
Even in the Korean general population exposed to high-air
pollution, long-term exposure of PM2.5 was almost linearly
associated with increased risks for all-cause and cardiovascular
mortality, especially above 18 mg/m3 of PM2.5. There might be
some susceptible patients who should beware of higher levels of
PM2.5.
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